| Neutrophils and contact activation of coagulation as potential drivers of COVID-19 MH Busch, SA Timmermans, M Nagy, M Visser, J Huckriede, ... Circulation 142 (18), 1787-1790, 2020 | 95 | 2020 |
| High-throughput elucidation of thrombus formation reveals sources of platelet function variability JP van Geffen, SLN Brouns, J Batista, H McKinney, C Kempster, M Nagy, ... Haematologica 104 (6), 1256, 2019 | 70 | 2019 |
| Store-operated calcium entry in thrombosis and thrombo-inflammation E Mammadova-Bach, M Nagy, JWM Heemskerk, B Nieswandt, A Braun Cell Calcium 77, 39-48, 2019 | 68 | 2019 |
| Sustained inflammation, coagulation activation and elevated endothelin-1 levels without macrovascular dysfunction at 3 months after COVID-19 LH Willems, M Nagy, H Ten Cate, HMH Spronk, LA Groh, J Leentjens, ... Thrombosis research 209, 106-114, 2022 | 62 | 2022 |
| Platelet function is modified by common sequence variation in megakaryocyte super enhancers R Petersen, JJ Lambourne, BM Javierre, L Grassi, R Kreuzhuber, ... Nature communications 8 (1), 16058, 2017 | 61 | 2017 |
| Atherothrombosis and thromboembolism: position paper from the Second Maastricht Consensus Conference on Thrombosis HMH Spronk, T Padro, JE Siland, JH Prochaska, J Winters, ... Thrombosis and haemostasis 118 (02), 229-250, 2018 | 59 | 2018 |
| The microbiota promotes arterial thrombosis in low-density lipoprotein receptor-deficient mice K Kiouptsi, S Jäckel, G Pontarollo, A Grill, MJE Kuijpers, E Wilms, ... MBio 10 (5), 10.1128/mbio. 02298-19, 2019 | 54 | 2019 |
| Platelet GPVI (glycoprotein VI) and thrombotic complications in the venous system G Perrella, M Nagy, SP Watson, JWM Heemskerk Arteriosclerosis, thrombosis, and vascular biology 41 (11), 2681-2692, 2021 | 53 | 2021 |
| Flow studies on human GPVI-deficient blood under coagulating and noncoagulating conditions M Nagy, G Perrella, A Dalby, MF Becerra, L Garcia Quintanilla, JA Pike, ... Blood advances 4 (13), 2953-2961, 2020 | 51 | 2020 |
| Variable impairment of platelet functions in patients with severe, genetically linked immune deficiencies M Nagy, TG Mastenbroek, NJA Mattheij, S De Witt, KJ Clemetson, ... Haematologica 103 (3), 540, 2018 | 43 | 2018 |
| Use of microfluidics to assess the platelet-based control of coagulation M Nagy, JWM Heemskerk, F Swieringa Platelets 28 (5), 441-448, 2017 | 41 | 2017 |
| Soluble platelet release factors as biomarkers for cardiovascular disease G Baidildinova, M Nagy, K Jurk, PS Wild, H Ten Cate, ... Frontiers in cardiovascular medicine 8, 684920, 2021 | 36 | 2021 |
| Comparison of the GPVI inhibitors losartan and honokiol MB Onselaer, M Nagy, C Pallini, JA Pike, G Perrella, LG Quintanilla, ... Platelets 31 (2), 187-197, 2020 | 33 | 2020 |
| Suggestions for global coagulation assays for the assessment of COVID-19 associated hypercoagulability TW van de Berg, AMM Hulshof, M Nagy, R van Oerle, JW Sels, ... Thrombosis research 201, 84-89, 2021 | 27 | 2021 |
| Defective Zn2+ homeostasis in mouse and human platelets with α- and δ-storage pool diseases S Kiran Gotru, JP van Geffen, M Nagy, E Mammadova-Bach, ... Scientific reports 9 (1), 8333, 2019 | 22 | 2019 |
| Complementary roles of platelet αIIbβ3 integrin, phosphatidylserine exposure and cytoskeletal rearrangement in the release of extracellular vesicles ACA Heinzmann, MFA Karel, DM Coenen, T Vajen, NMM Meulendijks, ... Atherosclerosis 310, 17-25, 2020 | 20 | 2020 |
| Native, intact glucagon-like peptide 1 is a natural suppressor of thrombus growth under physiological flow conditions M Sternkopf, M Nagy, CC Baaten, MJE Kuijpers, BME Tullemans, J Wirth, ... Arteriosclerosis, thrombosis, and vascular biology 40 (3), e65-e77, 2020 | 19 | 2020 |
| Tyrosine kinase inhibitor pazopanib inhibits platelet procoagulant activity in renal cell carcinoma patients BME Tullemans, M Nagy, S Sabrkhany, AW Griffioen, MGA oude Egbrink, ... Atherosclerosis and Vascular Medicine 5, 142, 2018 | 17 | 2018 |
| Comparative analysis of microfluidics thrombus formation in multiple genetically modified mice: link to thrombosis and hemostasis M Nagy, JP Van Geffen, D Stegner, DJ Adams, A Braun, SM De Witt, ... Frontiers in Cardiovascular Medicine 6, 99, 2019 | 16 | 2019 |
| Antiplatelet therapy in patients with COVID-19—more is less? B Spaetgens, M Nagy, H Ten Cate JAMA 327 (3), 223-224, 2022 | 14 | 2022 |
